Cargando…
Association of Preexisting Interstitial Lung Abnormalities With Immune Checkpoint Inhibitor–Induced Interstitial Lung Disease Among Patients With Nonlung Cancers
IMPORTANCE: Immune checkpoint inhibitor–induced interstitial lung disease (ICI-ILD) is clinically serious and life-threatening. Preexisting interstitial lung abnormalities have been shown to be risk factors for ICI-ILD in patients with lung cancer. OBJECTIVE: To evaluate whether interstitial lung ab...
Autores principales: | Shimoji, Kiyofumi, Masuda, Takeshi, Yamaguchi, Kakuhiro, Sakamoto, Shinjiro, Horimasu, Yasushi, Nakashima, Taku, Miyamoto, Shintaro, Iwamoto, Hiroshi, Fujitaka, Kazunori, Hamada, Hironobu, Takeno, Sachio, Hide, Michihiro, Teishima, Jun, Ohdan, Hideki, Hattori, Noboru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662135/ https://www.ncbi.nlm.nih.gov/pubmed/33180128 http://dx.doi.org/10.1001/jamanetworkopen.2020.22906 |
Ejemplares similares
-
Hypoxia-inducible factor 1α modulates interstitial pneumonia-mediated lung cancer progression
por: Shimoji, Kiyofumi, et al.
Publicado: (2023) -
High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery
por: Takao, Shun, et al.
Publicado: (2019) -
Non-small Cell Lung Cancer Treated by an Anti-programmed Cell Death-1 Antibody without a Flare-up of Preexisting Granulomatosis with Polyangiitis
por: Yamada, Takahiro, et al.
Publicado: (2019) -
Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients
por: Yamaguchi, Kakuhiro, et al.
Publicado: (2021) -
Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non‐small cell lung cancer
por: Wakabayashi, Yu, et al.
Publicado: (2020)